Navigation Links
Advent of New, More Effective and Personalized Medicines

The FDA today issued a final guidance titled "Pharmacogenomic Data Submissions" to speed// development of new medical products through the science of pharmacogenomics.

Pharmacogenomics allows health care providers to identify sources of an individual's profile of drug response and predict the best possible treatment option for this individual. This technology has enabled the development of targeted therapies like Herceptin for metastatic breast cancer, Gleevec for chronic myeloid leukemia and Erbitux for metastatic colorectal cancer.

This new approach will allow medicines to be uniquely crafted to maximize their therapeutic benefits and minimize the potential risks for each patient. Doctors will eventually be able to analyze a patient's genetic profile and prescribe the best available drug therapy and dose from the start.

FDA also approved the first laboratory test, the Amplichip Cytochrome P450 Genotyping Test, which will enable physicians to use genetic information to select the right doses of certain medications for cardiac, psychiatric diseases and cancer.

The final guidance describes what data will be needed during the marketing application review process, the format for submissions, and the data that will be used during regulatory decision-making. The guidance also explains a new mechanism for industry to voluntarily submit research data to further the scientific exchange of information as we move into more advanced areas of pharmacogenomic research.

The voluntary data, will be reviewed by an internal, agency-wide group and will not be used for regulatory decision making, but will help FDA and industry gain valuable experience. FDA believes this approach will save time and resources and eliminate possible delays in the application review process.

FDA has already received several pharmacogenomic data submissions through both the regulatory and voluntary processes and will continue to work cl osely with industry and the healthcare community.

In addition to announcing the availability of its final guidance and the new pharmacogenomic Web page, the agency also reminded the public of the meeting being held on pharmacogenomics issues.

The joint FDA/DIA meeting, "Pharmacogenomics in Drug Development and Regulatory Decision Making” will focus on integrating pharmacogenomics in clinical trials for new drugs, biologics, and associated devices. FDA will also address ways to translate pharmacogenomics into medical product development and clinical practice.


'"/>




Related medicine news :

1. Adventure Enthusiasts, Risk Takers and Those Living on the Edge, Good News Coming Your Way
2. Adrenaline Associated With Adventurers Risk Taking
3. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
4. Inhaled Steroids Safe & Effective for Children with Asthma
5. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
6. Fluoride Found Effective in Osteoporosis
7. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
8. Implantable Contact Lens Found Safe and Effective
9. Effective And Economical Agent For Anthrax
10. Stem Cell Transplants May Be Effective For MS Patients
11. Effective therapy for Huntingtons disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/20/2019)... ... 2019 , ... EBSCO Health , the leading provider ... the certification of two decision aids by the Washington State Health Care Authority, ... Yes or No? Currently, Washington is the only state requiring certification for shared ...
(Date:3/20/2019)... ... 2019 , ... Dr. Joe Lowrance, psychologist and founder of ... “Learn to practice mindfulness.” , In a white paper, “ The Mindful ... that financial advisors are discovering the power of mindfulness as a valuable tool ...
(Date:3/20/2019)... ... March 20, 2019 , ... VirtuOx, http://virtuox.net/ ... new way to diagnose cardiac arrhythmias in the patient’s home. , The VirtuOx ... utilizing mobile cardiac telemetry (MCT) in the convenience and comfort of the patient’s ...
(Date:3/20/2019)... ... 2019 , ... AutismOne has announced that Dr. Andrew Wakefield, an author and ... Wakefield's presentation at the AutismOne 2019 Conference will address what herd immunity is and ... lecture will examine the consequences - real and potential - for vaccines that do ...
(Date:3/20/2019)... , ... March 20, 2019 , ... Caring.com, the nation’s ... top medical alert systems for 2019. The medical alert provider was recognized as the ... companies that qualified for the list based on its demonstration of excellent customer service, ...
Breaking Medicine News(10 mins):
(Date:3/18/2019)... (PRWEB) , ... March 18, 2019 , ... ... intensive care unit (ICU) technology, today announced the publication of an article that ... technologies that may advance this critical component of patient care into the 21st ...
(Date:3/17/2019)... ... March 17, 2019 , ... ... test space announced a commercial agreement with Itamar Medical Ltd. which advances ... Lofta will integrate Itamar’s clinically validated diagnostic tool into their streamlined ...
(Date:3/15/2019)... ... March 15, 2019 , ... Dr. Srini Pillay , a best-selling author, ... chunk of his career subverting ideas on creativity and the processes behind human thinking. ... hit since its original release in 2017. , Now, Pillay is stating that creativity ...
Breaking Medicine Technology: